6 Undervalued Pharmaceuticals Stocks for Wednesday, August 19
Discover the top 6 undervalued Pharmaceuticals stocks for Wednesday, August 19 based on AAII’s Stock Grades.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Rosalio Madrigal
Cynthia McLaughlin
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | TLRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $655.0 | $632.9 | 40% |
|
| Shares Out (Mil) | 115.5 | 47.5 | 65% |
|
| Institutional Ownership | 80.2% | 85.0% | 49% |
|
| Float (Mil) | 133.4 | 47.4 | 67% |
|
| Beta | 1.92 | 0.68 | 91% |
|
| Avg Daily Volume (000s) | 3,711 | 370 | 89% |
|
| Price Change (52-week) |
(57.6%) | 68.8% | 12% |
|
| Growth | TLRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.3% | 6.6% | 66% |
|
| Net Income (5yr) | 19.9% | (1.5%) | 73% |
|
| EPS (5yr) | 39.7% | 14.9% | 88 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (57.0%) | (14.9%) | 5% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | na | |
| Current EPS | $0.050 | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | 0 | na | na | |
| # Rev Down | 2 | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | (111.4%) | na | (145.9%) | |
| Financials | TLRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $916 | $283 | 49% |
|
| Net Income (TTM) (Mil) | ($121) | ($11) | 10% |
|
| EPS (TTM) | ($1.086) | ($0.700) | 20% |
|
| Operating Cash Flow (TTM) (Mil) | ($69) | ($6) | 8% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $5 | 54% |
|
| Long-Term Debt (Q1) (Mil) | $358 | $6 | 55% |
|
| Enterprise Value (Q1) (Mil) | $777 | $525 | 37% |
|
| Valuation | TLRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.39 | 2.85 | 6% |
|
| P/E | na | 17.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | TLRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 28.7% | 66.2% | 33% |
|
| Net Margin | (13.3%) | (3.1%) | 19% |
|
| ROA | (5.5%) | (22.0%) | 29% |
|
| ROE | (7.8%) | (19.3%) | 29% |
|
| Liabilities to Assets | 31.5% | 32.8% | 22% |
|
| F-Score | 3 | 3 | 18% |
|
Tilray Brands, Inc. did not pass any screens on 8/19/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors